SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is facing mounting pressure on multiple fronts. Following disappointing sales figures and ongoing ...

SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is facing mounting pressure on multiple fronts. Following disappointing sales figures and ongoing ...

An enormous accomplishment no matter what your finish time or experience level, conquering a marathon is always worth the work that you put in. But in the midst of all your marathon training ...

SAN DIEGO (AP) — Denny McCarthy ended a miserable day in a most brilliant manner Thursday at the Genesis Invitational, closing birdie-eagle for a 4-under 68 on a Torrey Pines course that more ...

--(BUSINESS WIRE)--#CMO--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics ...

Selkirk Pharma, a U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, has launched ClinFAST, a service designed to ...

A step-by-step guide to help you fill out a W-4 Thanasis / Getty Images You're about to begin that much-needed, new job and your employer hands you an IRS Form W-4 to fill out and submit to them ...

Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.

Regeneron, which is seeking FDA approval of linvoseltamab for adults with relapsed/refractory multiple myeloma that has progressed after at least three prior therapies, said the agency set a new ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.